Core Viewpoint - Hualan Co., Ltd. (301093.SZ) announced a collaboration between its wholly-owned subsidiary Hainan Lingqing Smart Pharmaceutical Technology Co., Ltd. and a technical team led by former CTO of Insilico Medicine, Yu Kaixian, and Academician Liu Jun from the American Academy of Sciences [1] Group 1 - The collaboration involves the establishment of a joint venture company, with Hualan's subsidiary holding a controlling stake [1] - The joint venture will focus on drug repurposing and pharmacovigilance services centered around knowledge graphs, integrating heterogeneous data sources to provide intelligent solutions for drug development and safety management [1] - The specific business scope of the joint venture will be determined based on industrial registration information [1]
华兰股份(301093.SZ)：子公司拟设立合资公司聚焦于以知识图谱为核心的药物重定向与药物警戒相关服务